How to read the table
Each row summarises one market guide. Buyers are the organisations that run tenders, not the sites where tenders are published. The award model shows whether a lot usually has one winner or several, which decides how results should be read.
Main medicine buyers by market
| Market | Main buyers | Award model |
|---|---|---|
| Germany | Statutory health insurers (AOK, TK, BARMER, DAK, IKK and BKK groups); hospital purchasing groups; public university and municipal hospitals | Lowest price per lot; many insurers award up to three partners per lot |
| France | UniHA, Resah and AGEPS (AP-HP); regional hospital groups (GHT); UGAP for some categories | Multi-criteria: price with quality, supply security and service, plus at least one environmental criterion since August 2026 |
| Italy | Regional central purchasing bodies (for example ARIA, SoReSa, Intercent-ER, ESTAR, Azienda Zero); local health authorities and hospitals below the threshold | Mostly lowest price, some quality-price awards; biosimilar frameworks ranked, with patients treated with one of the first three |
| Spain | INGESA (national centralised purchasing); regional health services such as SAS, SERMAS, CatSalut and ICS, Osakidetza and SERGAS; individual hospitals | Multi-criteria, typically price plus quality, service and sustainability criteria |
| Netherlands | Health insurers for outpatient medicines; hospitals and hospital purchasing groups for inpatient and specialist medicines | Lowest price for preference policy; hospital tenders often multi-criteria |
| Belgium | Individual hospitals and loco-regional hospital networks; joint tenders between hospitals | Multi-criteria, with price, quality and service; several criteria are banned for biologicals |
| United Kingdom | National NHS commercial teams (the Commercial Medicines Unit) for hospital medicines; NHS Supply Chain for devices and consumables; NHS National Services Scotland; NHS Wales Shared Services Partnership | Price with service and supply criteria; England often multi-supplier per line by region, Scotland single or unranked multi-supplier |
| Nordics | Amgros (Denmark); Sykehusinnkjøp HF (Norway); the Swedish regions, often jointly by healthcare region; Finnish wellbeing services counties and their joint purchasing units | Price-led, with environmental and supply criteria playing a growing role |
| Austria and Switzerland | Austria: the state hospital operators and the Bundesbeschaffung GmbH (BBG) for selected medicines. Switzerland: cantonal and university hospitals and their purchasing groups | Austria: mostly lowest price. Switzerland: price with quality and supply criteria |
| Portugal, Ireland and Greece | Portugal: SPMS and the 39 local health units (ULS) formed in 2024. Ireland: the Health Service Executive. Greece: EKAPY and public hospitals | Mostly price-led |
| Central and Eastern Europe | Individual public hospitals; national central purchasing in Romania and Hungary; the health insurers in Czechia from 2026 | Predominantly lowest price |
Questions
Who buys hospital medicines in Europe?
Mostly regional or national purchasing bodies and hospital groups, plus individual hospitals for smaller purchases. The mix differs by country: Italy buys through regional central bodies, France through national purchasing groups, Denmark through one national body.